The genetics of multiple drug resistance in Mycobacterium tuberculosis and the Mycobacterium avium complex

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 68-73

  Morris, S L ^a   Rouse, D A ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

CONFERENCE PAPER; HUMAN; MULTIDRUG RESISTANCE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

EID: 0029988593     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80206-3     Document Type: Conference Paper

References (40)

1. Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K.S., Wilson, T., Collins, D., de Lisle, G. & Jacobs, W.R. (1994), inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science, 263, 227-230.
2. Brennan, P.J. & Nikaido, H. (1995), The envelope of mycobacteria. Annu. Rev. Biochem., 64, 29-63.
3. David, H.L., Rastogi, N., Clavel-Seres, S. & Clement, F. (1988), Alteration in the outer wall architecture caused by inhibition of mycoside C biosynthesis in Mycobacterium avium. Curr. Microbiol., 17, 61-68.
4. Deng, L., Mikusová, K., Robuck, K., Scherman, M., Brennan, P.J. & McNeil, M.R. (1995), Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob. Agents Chemother., 39, 694-701.
5. Dooley, S.W., Jarvis, W.R., Martone, W.J. & Snider, D.E. (1992), Multidrug-resistant tuberculosis. Ann. Intern. Med., 117, 257-259.
6. Finken, M., Kirschner, P., Meier, A., Wrede, A. & Böttger, E.C. (1993), Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within the functional 16S ribosomal RNA pseudoknot. Mol. Microbiol., 9(6), 1239-1246.
7. Foster, P.C. (1993), Adaptive mutation: the uses of adversity. Annu. Rev. Microbiol., 47, 467-501.
8. Frieden, T.R., Sterling, T., Pablos-Mendez, A., Kilburn, J.O., Cauthen, G.M. & Dooley, S.W. (1993), The emergence of drug-resistant tuberculosis in New York City. N. Engl. J. Med., 328, 521-526.
9. Grandes, C., Lopez-de-Munain, J., Diaz, T. & Rullan, J.V. (1993), Drug-resistant tuberculosis in Puerto Rico, 1987-1990. Am. Rev. Respir. Dis., 148, 6-9.
10. Guerro, C., Stockman, L., Marchesi, F., Bodmer, T., Roberts, G.D. & Telenti, A. (1994), Evaluation of the rpoB gene in rifampicin-susceptible and -resistant Mycobacterium avium and Mycobacterium intracellulare. J. Antimicrob. Chemother., 33, 661-663.
11. Heifets, L. (1988), MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Antimicrob. Agents Chemother., 32, 1131-1136.
12. Heym, B., Honoré, N., Truffot-Pernot, C., Barnerjee, A., Schurra, C., Jacobs, W.R., van Embden, J.D.A., Grosset, J.H. & Cole, S.T. (1994), Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet, 344, 293-298.
13. Hoffner, S.E., Kratz, M., Olsson-Liljequist, B., Svenson, S.B. & Källenius, G. (1989), In vitro synergistic activity between ethambutol and fluorinated quinolones against Mycobacterium avium complex. J. Antimicrob. Chemother., 24, 317-324.
14. Honoré, N. & Cole, S.T. (1994), Streptomycin resistance in mycobacteria. Antimicrob. Agents Chemother., 38, 238-242.
15. Horsburgh, C.R. (1991), Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N. Engl. J. Med., 324, 1332-1338.
16. Jarlier, V. & Nikaido, H. (1990), Permeability barrier to hydrophilic solutes in Mycobacterium chelonei. J. Bacteriol., 172, 1418-1423.
17. Kent, J.H. (1993), The epidemiology of multi-drug resistant tuberculosis in the United States. Med. Clin. North Am., 77, 1391-1409.
18. Lewis, K. (1994), Multidrug resistance pumps in bacteria: variations on a theme. TIBS, 19, 119-123.
19. Masur, H. & The Public Health Service Task Force on Prophylaxis and Therapy for the Mycobacterium avium Complex (1993), Recommendations on the prophylaxis and therapy for disseminated Mycobacterium avium complex disease in patients with the immunodeficiency virus. N. Eng. J. Med., 329, 898-903.
20. Mdluli, K.E., Treit, J.D., Kerr, V.J., Doran, J.L. & Nano, F.E. (1995), Identification of an efflux protein of Mycobacterium tuberculosis. Abstracts of the Ninety-fifth General Meeting of the American Society for Microbiology, p. 140.
21. Meier, A., Kirschner, P., Bange, F., Vogel, U. & Böttger, E.C. (1994), Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob. Agents Chemother., 38, 228-233.
22. Morris, S.L., Bai, G.H., Suffys, P., Portillo-Gomez, L., Fairchok, M. & Rouse, D.A. (1995), Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis., 171, 954-960.
23. Nair, J., Rouse, D.A., Bai, G.H. & Morris, S.L. (1993), The rpsL gene and streptomycin resistance in single and multiple drug resistant strains of Mycobacterium tuberculosis. Mol. Microbiol., 10, 521-527.
24. Nikaido, H. (1994), Prevention of drug access to bacterial targets: barriers and active efflux. Science, 264, 382-387.
25. Portillo-Gomez, L., Nair, J., Morris, S.L. & Rouse, D.A. (1995), The absence of genetic markers for streptomycin and rifampicin resistance in Mycobacterium avium complex strains. J. Antimicrob. Chemother. (in press).
26. Rastogi, N., Goh, K.S. & David, H.L. (1990), Enhancement of drug susceptibility of Mycobacterium avium by inhibitors of cell envelope synthesis. Antimicrob. Agents Chemother., 34, 759-764.
27. Rastogi, N. & Goh, K.S. (1990), Antibacterial action of 1-isonicotinyl-2-palmitoyl hydrazine against Mycobacterium avium complex and the enhancement of its activity by m-flouro-phenylalanine. Antimicrob. Agents Chemother., 34, 2061-2064.
28. Rastogi, N. (1991), Recent observations concerning structure and function relationships in the mycobacterial cell envelope: elaboration of model in terms of mycobacterial pathogenicity, virulence and drug-resistance, in "7th Forum in Microbiology", Res. Microbiol., 142, 464-476.
29. Rastogi, N., Ross, B.C., Dwyer, B., Goh, K.S., Clavel-Sérès, S., Jeantils, V. & Cruaud, P. (1992), Emergence during unsuccessful chemotherapy of multiple drug resistance in a strain of Mycobacterium tuberculosis. Eur. J. Clin. Microbiol. Infect. Dis., 11, 901-907.
30. Rouse, D.A. & Morris, S.L. (1995), Molecular mechanisms of isoniazid resistance in Mycobacterium tuberculosis and Mycobacterium bovis. Infect. Immun., 63, 1427-1433.
31. Rouse, D.A., Li, Z., Bai, G. & Morris, S.L. (1995), Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 39, 2472-2477.
32. Sander, P., Meier, A. & Böttger, B.C. (1995), rpsL, a dominant selectable marker for gene replacement in mycobacteria. Mol. Microbiol., 16, 991-1000.
33. Sareen, M. & Khuller, G.K. (1990), Cell wall and membrane changes associated with ethambutol resistance in Mycobacterium tuberculosis H37Ra. Antimicrob. Agents Chemother., 34, 1773-1776.
34. Scalcini, M., Carre, G., Jean-Baptiste, M., Hershfield, E., Parker, S., Wolfe, J., Nelz, K. & Long, R. (1990), Antituberculous drug resistance in central Haiti. Am. Rev. Respir. Dis., 142, 508-511.
35. Takayama, K. & Kilburn, J.O. (1989), Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob. Agents Chemother., 33, 1493-1499.
36. Takiff, H.E., Salazar, L., Guerrero, C., Phillip, W., Huang, Kreiswirth, W.M., Cole, S.T., Jacobs, W.R. & Telenti, A. (1994), Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother., 38, 773-780.
37. Telenti, A., Imboden, P., Marchesi, F., Lowerie, D., Cole, S., Colston, M.J., Matter, L., Schopfer, K. & Bodmer, T. (1993), Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650.
38. Trias, J., Jarlier, V. & Benz, R. (1992), Porins in the cell wall of mycobacteria. Science, 258, 1479-1481.
39. Williams, D.L., Waguespack, C., Eisenach, K., Crawford, J.T., Portaels, F., Salfinger, M., Nolan, C.M., Abe, C., Sticht-Groh, V. & Gillis, T.P. (1994), Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother., 38, 2380-2386.
40. Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, S. (1992), The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature (Lond.), 358-591-593.